Annalisa Berzigotti
@docberza
Followers
3K
Following
3K
Media
193
Statuses
2K
Hepatologist in Berne, with a passion for ultrasound, research, and human beings.
Joined May 2011
Ciao Jaume, goodbye cariño mio. You have been such a special and wonderful man and I will love you forever.
36
22
208
RT @JHepatology: 📢Our new Impact Factor is 33.0🎉. 🥇Ranking number 1 in the Hepatology field once again!. 👏Thanks to the Editorial Team, unt….
0
24
0
RT @tomhemmingk: Impact factors as of 2025 have been released. Proud to be part of the editors team of @EASLnews @JHepatology - standing on….
0
11
0
Great presentation of our dear Manuel Prampolini at the EASL congress in Amsterdam! @EASLnews @EricFelli @JSGracia.
1
3
15
RT @MattiasMandorf1: 📢 First EASL CPG on surgery in cirrhosis presented today together with the one on TIPS!.🤝 See you at 10:30 Erlinger Ro….
0
4
0
RT @EASLnews: 🏆Professor Annalisa Berzigotti has been honoured with the EASL Community Award at #EASLCongress, recognising her exceptional….
0
13
0
RT @BavenoCoop: Great audience at the session with @BavenoCoop at #EASL2025 Amsterdam! Key messages:. 1️⃣ Membership is free and easy at ht….
0
9
0
RT @BavenoCoop: ESGE and Baveno together – what a team! 🔥. Key messages:.🔹 Just because it’s technically feasible doesn’t mean it should be….
0
29
0
RT @BavenoCoop: And last but not least. 💡Uncover the methodological pitfalls in observational studies in Hepatology. Ensure your researc….
0
7
0
RT @BavenoCoop: ❓How can we go beyond binary outcomes in assessing treatment effects in ACLD? . 💡Learn about hierarchical outcomes, recurre….
0
9
0
RT @tom_marjot: 1: In 2025, look out for a new section in @JHepatology: "Breakthroughs Beyond the Journal". Editorial-style analyses of pi….
0
12
0
RT @ReibergerThomas: You can continue #Anticoagulation when you perform #endoscopicbandligation #ELB for #varices. When Undergoing Endoscop….
0
28
0
RT @CirrhosisCareAB: 🩺Direct your patients and caregivers to for a comprehensive set of modules on cirrhosis. It’s….
0
17
0
RT @JHepatology: 🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️. ✅Updated advice for managing patients….
0
142
0
RT @AleksanderKrag: @EASLnews @TheLancet Commission on Liver Health. Interdisciplinary group gathered in Geneva! @ECDC_EU @WHO_Europe @EASO….
0
6
0
RT @BavenoCoop: 🚨Don’t miss the Baveno VIII Pre-Symposium Webinar: Designing Clinical Studies in Advanced Chronic Liver Disease . A must-a….
0
24
0
RT @BavenoCoop: Join the @BavenoCoop family to:. 1️⃣ Stay updated on #PortalHypertension.2️⃣ Participate in studies.3️⃣ Young/experienced m….
0
8
0
RT @Brunorm84: Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of #MASH @….
journal-of-hepatology.eu
Metabolic dysfunction-associated steatohepatitis (MASH) is one of the most common liver diseases worldwide and is characterized by multi-tissue insulin resistance. The effects of a 10-month energy...
0
20
0